New Delhi, July 11 (IANS) The Maharashtra Food and Drug Administration (FDA) has barred the sale and distribution of certain medicines manufactured by Cadila Pharmaceuticals Ltd and seized stock worth around Rs 2.45 crore over concerns that similar branding could lead to medication errors, as per multiple reports.It also directed the company to recall select products from the market, it added.The action relates to Aciloc 150, Aciloc 150 Plus, Aciloc 300 and Aciloc 300 Plus, which contain differe…
Trending
- Vadhandhi Season 2 Review (2026): A Gripping, Powerful Thriller Anchored By Sasikumar’s Career-Best Performance
- Picture 2026 Movie Review: A Heartwarming Kannada-Tulu Family Entertainer That Wins You Over
- Thudakkam Movie Review (2026): Vismaya Mohanlal Delivers a Powerful, Star-Making Debut
- Operation Safed Sagar Review 2026: A Powerful Tribute To Kargil’s Air Warriors
- DC Movie Review 2026: Wamiqa Gabbi’s Fierce Performance Make This Saga a Massive Triumph
- Korean Kanakaraju Movie Review 2026: An Unmissable Cross-Border Ride
- Ohh My Dog Movie Review 2026: A Heartwarming Triumph Of Loyalty & Love
- G.D.N. Movie Review: Madhavan’s Powerhouse Biopic Is a Tribute to India’s Forgotten Edison